MedPath
FDA Approval

Rivastigmine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
October 3, 2022
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Rivastigmine(9.5 mg in 24 h)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Zydus Pharmaceuticals USA Inc.

156861945

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Zydus Lifesciences Limited

Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc.

650461283

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Rivastigmine

Product Details

NDC Product Code
70710-1197
Application Number
ANDA206318
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
October 3, 2022
Code: PKI06M3IW0Class: ACTIBQuantity: 9.5 mg in 24 h
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37XClass: IACT
POLYISOBUTYLENE (55000 MW)Inactive
Code: TQ77WR8A02Class: IACT

Rivastigmine

Product Details

NDC Product Code
70710-1196
Application Number
ANDA206318
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
October 3, 2022
POLYISOBUTYLENE (55000 MW)Inactive
Code: TQ77WR8A02Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37XClass: IACT
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
Code: PKI06M3IW0Class: ACTIBQuantity: 4.6 mg in 24 h

Rivastigmine

Product Details

NDC Product Code
70710-1198
Application Number
ANDA206318
Marketing Category
ANDA (C73584)
Route of Administration
TRANSDERMAL
Effective Date
October 3, 2022
Code: PKI06M3IW0Class: ACTIBQuantity: 13.3 mg in 24 h
LIGHT MINERAL OILInactive
Code: N6K5787QVPClass: IACT
POLYISOBUTYLENE (1100000 MW)Inactive
Code: FLT10CH37XClass: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
POLYISOBUTYLENE (55000 MW)Inactive
Code: TQ77WR8A02Class: IACT
© Copyright 2025. All Rights Reserved by MedPath